Simultaneous inhibition of PFKFB3 and GLS1 selectively kills KRAS-transformed pancreatic cells
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 571, 118-124
Abstract
No abstract availableKeywords
Funding Information
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (114Z496)
- Bursa Uludağ University (DDP(F)-2018/3)
This publication has 19 references indexed in Scilit:
- 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27Cell Death & Disease, 2014
- Estradiol Stimulates Glucose Metabolism via 6-Phosphofructo-2-kinase (PFKFB3)Journal of Biological Chemistry, 2014
- KRAS: feeding pancreatic cancer proliferationTrends in Biochemical Sciences, 2014
- Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathwayNature, 2013
- Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolismCancer & Metabolism, 2013
- Nuclear Targeting of 6-Phosphofructo-2-kinase (PFKFB3) Increases Proliferation via Cyclin-dependent KinasesJournal of Biological Chemistry, 2009
- K-Ras Promotes Growth Transformation and Invasion of Immortalized Human Pancreatic Cells by Raf and Phosphatidylinositol 3-Kinase SignalingCancer Research, 2007
- Ras transformation requires metabolic control by 6-phosphofructo-2-kinaseOncogene, 2006
- Western blottingMethods, 2006
- A Kinetic Study of Pyrophosphate: Fructose‐6‐Phosphate Phosphotransferase from Potato TubersEuropean Journal of Biochemistry, 1982